Want to join the conversation?
$VRTX 2Q15 Call: Through both geographic and label expansion, Vertex has continued to grow the number of patients treated with KALYDECO, resulting in strong revenue growth. With ORKAMBI approval and launch in US, the company has an even greater opportunity to treat more patients, resulting in additional revenue growth.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!